Mechanism of the prolactin rebound after dopamine withdrawal in rat pituitary cells.

To study the mechanism underlying the effect of dopamine withdrawal on prolactin release, continuous perfusion experiments were performed on rat lactotroph-enriched primary cultures. Removal of dopamine (10(-7) M) after a short-term application (15 min) produced a rebound of prolactin secretion, which was enhanced by pretreatment of the cell culture with 17 beta-estradiol (10(-8) M for 48 h). Ca2+ channel blockade by Co2+ (1 mM) abolished the rebound in prolactin release. An increase in intracellular adenosine 3',5'-cyclic monophosphate by either forskolin (5 microM) or 3-isobutyl-1-methylxanthine (100 microM) enhanced the prolactin rebound after dopamine withdrawal. Application of thyrotropin-releasing hormone (10(-7) M) increased the prolactin rebound after dopamine withdrawal with a maximum effect obtained by commencing treatment immediately after removal of dopamine. Pretreatment of cell cultures with pertussis toxin (100 ng/ml, for 10 h) totally abolished the effects of dopamine on prolactin secretion. The dopamine agonist bromocriptine (10(-9) M) significantly decreased prolactin secretion, but no rebound effect was observed after its removal. We conclude that the rebound of prolactin release after dopamine treatment involves the influx of Ca2+.

[1]  A. M. Gordon,et al.  Ca(2+)-dependence of structural changes in troponin-C in demembranated fibers of rabbit psoas muscle. , 1992, Biophysical journal.

[2]  S. G. Smith,et al.  The stimulatory and inhibitory effects of dopamine on prolactin secretion involve different G-proteins. , 1992, Endocrinology.

[3]  T. Burris,et al.  Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland. , 1991, Neuroendocrinology.

[4]  J. Vincent,et al.  Functional Lactotroph Heterogeneity in Lactating Rats and in vitro Modification by 17Beta‐Estradiol , 1990, Journal of neuroendocrinology.

[5]  J. Vincent,et al.  A guanine nucleotide-binding protein mediates the inhibition of voltage-dependent calcium currents by dopamine in rat lactotrophs , 1990, Brain Research.

[6]  J. Vincent,et al.  Dopamine inhibits two characterized voltage-dependent calcium currents in identified rat lactotroph cells. , 1990, Endocrinology.

[7]  J. Vincent,et al.  Plateau potentials recorded from lactating rat enriched lactotroph cells are triggered by thyrotropin releasing hormone and shortened by dopamine. , 1990, Neuroendocrinology.

[8]  J. Vincent,et al.  In vitro Effects of 17Beta‐Estradiol on Thyrotropin‐Releasing Hormone‐Induced and Dopamine‐lnhibited Prolactin Release from Adult Male Rat Lactotrophs in Primary Culture , 1990, Journal of neuroendocrinology.

[9]  J. Vincent,et al.  Two types of voltage‐dependent calcium current in rat somatotrophs are reduced by somatostatin. , 1990, The Journal of physiology.

[10]  J. Vincent,et al.  Electrophysiological responses of rat pituitary cells in somatotroph-enriched primary culture to human growth-hormone releasing factor. , 1989, Neuroendocrinology.

[11]  D. Sibley,et al.  Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland. , 1989, Endocrinology.

[12]  J. Israel,et al.  Electrophysiological responses to somatostatin of rat hypophysial cells in somatotroph‐enriched primary cultures. , 1989, The Journal of physiology.

[13]  R. Weiner,et al.  Effect of dopamine withdrawal on activation of adenylate cyclase and phospholipase C in enriched lactotrophs. , 1988, Endocrinology.

[14]  M. Thorner,et al.  Intracellular calcium concentration and growth hormone secretion in individual somatotropes: effects of growth hormone-releasing factor and somatostatin. , 1988, Endocrinology.

[15]  R. Weiner,et al.  Mechanism(s) by which the transient removal of dopamine regulation potentiates the prolactin-releasing action of thyrotropin-releasing hormone. , 1988, Neuroendocrinology.

[16]  C. Pasqualini,et al.  Direct effect of estradiol on the number of dopamine receptors in the anterior pituitary of ovariectomized rats. , 1986, Endocrinology.

[17]  R. Collu,et al.  Role of calcium and sodium ions in the inhibitory control of baseline and stimulated prolactin release. , 1986, Endocrinology.

[18]  W. Klootwijk,et al.  Levels of dopamine and thyrotrophin-releasing hormone in hypophysial stalk blood during an oestrogen-stimulated surge of prolactin in the ovariectomized rat. , 1985, The Journal of endocrinology.

[19]  M. Baes,et al.  Stimulation of prolactin secretion after short term or pulsatile exposure to dopamine in superfused anterior pituitary cell aggregates. , 1984, Endocrinology.

[20]  J. Schofield.  Use of a trapped fluorescent indicator to demonstrate effects of thyroliberin and dopamine on cytoplasmic calcium concentrations in bovine anterior pituitary cells , 1983, FEBS letters.

[21]  J. D. Neill,et al.  Neuroendocrine control of prolactin secretion. , 1983, Annual review of physiology.

[22]  K. Ray,et al.  Involvement of calcium ions in dopamine inhibition of prolactin secretion from sheep pituitary cells , 1982, Molecular and Cellular Endocrinology.

[23]  C. Denef,et al.  Physiological concentrations of dopamine decrease adenosine 3',5'-monophosphate levels in cultured rat anterior pituitary cells and enriched populations of lactotrophs: evidence for a causal relationship to inhibition of prolactin release. , 1982, Endocrinology.

[24]  P. Plotsky,et al.  Interactions of dopamine and thyrotropin-releasing hormone in the regulation of prolactin release in lactating rats. , 1982, Endocrinology.

[25]  P. Claude,et al.  Prolactin synthesis in primary cultures of pituitary cells: Regulation by estradiol , 1982, Molecular and Cellular Endocrinology.

[26]  G. Giannattasio,et al.  Dopamine-inhibited adenylate cyclase in female rat adenohypophysis. , 1981, Life sciences.

[27]  J. T. Hackett,et al.  Calcium rather than cyclic AMP as the physiological intracellular regulator of prolactin release. , 1980, Neuroendocrinology.

[28]  P. Camilli,et al.  Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas , 1979, Nature.

[29]  G. D. Barnes,et al.  Effect of TRH and dopamine on cyclic AMP levels in enriched mammotroph and thyrotroph cells , 1978, Molecular and Cellular Endocrinology.

[30]  W. Douglas,et al.  Catecholamines of supposed inhibitory hypophysiotrophic function suppress action potentials in prolactin cells , 1978, Nature.

[31]  M. Baudry,et al.  Increased in vivo binding of 3H-pimozide in mouse striatum following repeated administration of haloperidol. , 1978, Life sciences.

[32]  B. Vanderschueren,et al.  Pituitary basophils from immature male and female rats: distribution of gonadotrophs and thyrotrophs as studied by unit gravity sedimentation. , 1978, Endocrinology.

[33]  C. Denef,et al.  A specific population of gonadotrophs purified from immature female rat pituitary , 1976 .